Design of intrahepatocyte copper(I) chelators as drug candidates for Wilson's disease

Annals of the New York Academy of Sciences

Volumn 1315, Issue 1, 2014, Pages 30-36

  Gateau, Christelle ^a   Delangle, Pascale ^a  

^a CEA GRENOBLE   (France)

Author keywords

Copper(I); Hepatic cells; Sulfur ligands; Wilson's disease

Indexed keywords

CHELATING AGENT; CUPROUS ION; LEWISITE; METALLOTHIONEIN; PENICILLAMINE; TETRATHIOMOLYBDIC ACID; TRIENTINE;

ARTICLE; BINDING AFFINITY; BINDING SITE; CHELATION THERAPY; COMPLEX FORMATION; DRUG DESIGN; DRUG STRUCTURE; DRUG TARGETING; HOMEOSTASIS; HUMAN; LIGAND BINDING; LIVER CELL; OXIDATION; WILSON DISEASE;

COPPER(I); HEPATIC CELLS; SULFUR LIGANDS; WILSON'S DISEASE;

ASIALOGLYCOPROTEIN RECEPTOR; CHELATING AGENTS; COPPER; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GLYCOCONJUGATES; HEPATOCYTES; HEPATOLENTICULAR DEGENERATION; HUMANS; LIGANDS; METALLOTHIONEIN; OXIDATION-REDUCTION;

EID: 84900024218     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12379     Document Type: Article

References (46)

1. Huster, D. 2010. Wilson disease. Best Pract. Res. Clin. Gastroenterol. 24: 531-539.
2. Delangle, P. & E. Mintz. 2012. Chelation therapy in Wilson's disease: from D-penicillamine to the design of selective bioinspired intracellular Cu(I) chelators. Dalton Trans. 41: 6359-6370.
3. Gourdon, P. et al. 2011. Crystal structure of a copper-transporting PIB-type ATPase. Nature 475: 59-64.
4. Lutsenko, S. et al. 2007. Function and regulation of human copper-transporting ATPases. Physiol. Rev. 87: 1011-1046.
5. Walshe, J.M. 2006. History of Wilson's disease: 1912 to 2000. Mov. Disord. 21: 142-147.
6. Gitlin, J.D. 2003. Wilson disease. Gastroenterology 125: 1868-1877.
7. Kinnier Wilson, S.A. 1912. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain 34: 295-507.
8. Sarkar, B. 1999. Treatment of Wilson and Menkes diseases. Chem. Rev. 99: 2535-2544.
9. Peters, R.A., L.A. Stocken & R.H. Thompson. 1945. British anti-Lewisite (BAL). Nature 156: 616-619.
10. Vilensky, J.A. & K. Redman. 2003. British anti-Lewisite (dimercaprol): an amazing history. Ann. Emerg. Med. 41: 378-383.
11. Brewer, G.J. 2009. Drug development for orphan diseases in the context of personalized medicine. Transl. Res. 154: 314-322.
12. Pujol, A.M. et al. 2011. Hepatocyte targeting and intracellular copper chelation by a thiol-containing glycocyclopeptide. J. Am. Chem. Soc. 133: 286-296.
13. Pearson, R.G. 1963. Hard and soft acids and bases. J. Am. Chem. Soc. 85: 3533-3539.
14. Pearson, R.G. & J. Songstad. 1967. Application of principle of hard and soft acids and bases to organic chemistry. J. Am. Chem. Soc. 89: 1827-1836.
15. Stillman, M.J. 1995. Metallothioneins. Coord. Chem. Rev. 144: 461-511.
16. Vasak, M. & G. Meloni. 2011. Chemistry and biology of mammalian metallothioneins. J. Biol. Inorg. Chem. 16: 1067-1078.
17. Wernimont, A.K. et al. 2000. Structural basis for copper transfer by the metallochaperone for the Menkes/Wilson disease proteins. Nat. Struct. Biol. 7: 766-771.
18. Kim, B.E., T. Nevitt & D.J. Thiele. 2008. Mechanisms for copper acquisition, distribution and regulation. Nat. Chem. Biol. 4: 176-185.
19. Ohgami, R.S. et al. 2006. The Steap proteins are metalloreductases. Blood 108: 1388-1394.
20. Freedman, J.H., M.R. Ciriolo & J. Peisach. 1989. The role of glutathione in copper metabolism and toxicity. J. Biol. Chem. 264: 5598-5605.
21. Arnesano, F. et al. 2002. Metallochaperones and metal-transporting ATPases: a comparative analysis of sequences and structures. Genome Res. 12: 255-271.
22. Rousselot-Pailley, P. et al. 2006. Model peptides based on the binding loop of the copper metallochaperone Atx1: selectivity of the consensus sequence MxCxxC for metal ions Hg(II), Cu(I), Cd(II), Pb(II), and Zn(II). Inorg. Chem. 45: 5510-5520.
23. Seneque, O. et al. 2004. Novel model peptide for Atx1-like metallochaperones. Chem. Commun. 7: 770-771.
24. Palacios, O., S. Atrian & M. Capdevila. 2011. Zn- and Cu-thioneins: a functional classification for metallothioneins? J. Biol. Inorg. Chem. 16: 991-1009.
25. Calderone, V. et al. 2005. The crystal structure of yeast copper thionein: the solution of a long-lasting enigma. Proc. Natl. Acad. Sci. U. S. A. 102: 51-56.
26. Koch, K.A., M.M. Pena & D.J. Thiele. 1997. Copper-binding motifs in catalysis, transport, detoxification and signaling. Chem. Biol. 4: 549-560.
27. Faller, P. 2010. Neuronal growth-inhibitory factor (metallothionein-3): reactivity and structure of metal-thiolate clusters. FEBS J. 277: 2921-2930.
28. Bogumil, R. et al. 1998. Structural characterization of Cu(I) and Zn(II) sites in neuronal-growth-inhibitory factor by extended X-ray absorption fine structure (EXAFS). Eur. J. Biochem. 255: 172-177.
29. Pujol, A.M. et al. 2011. A series of tripodal cysteine derivatives as water-soluble chelators highly selective for Copper (I). Chem. Eur. J. 17: 4418-4428.
30. Pujol, A.M. et al. 2009. A cysteine-based tripodal chelator with a high affinity and selectivity for copper(I). J. Am. Chem. Soc. 131: 6928-6929.
31. Pujol, A.M. et al. 2012. Mercury-sequestering pseudopeptides with a triscysteine environment in water. Eur. J. Inorg. Chem. 3835-3843.
32. Nielson, K.B., C.L. Atkin & D.R. Winge. 1985. Distinct metal-binding configurations in metallothionein. J. Biol. Chem. 260: 5342-5350.
33. Presta, A. et al. 1995. Copper-binding to rabbit liver metallothionein-formation of a continuum of copper(I)-thiolate stoichiometric species. Eur. J. Biochem. 227: 226-240.
34. Jullien, A.-S. et al. 2013. X-ray absorption spectroscopy proves the trigonal planar sulfur-only coordination of Cu(I) with high affinity tripodal pseudopeptides. Inorg. Chem. 52: 9954-9961.
35. Spiess, M. 1990. The asialoglycoprotein receptor: a model for endocytic transport receptors. Biochemistry 29: 10009-10018.
36. Meier, M. et al. 2000. Crystal structure of the carbohydrate recognition domain of the H1 subunit of the asialoglycoprotein receptor. J. Mol. Biol. 300: 857-865.
37. Ashwell, G. & J. Harford. 1982. Carbohydrate-specific receptors of the liver. Annu. Rev. Biochem. 51: 531-554.
38. Lee, Y.C. & R.T. Lee 1995. Carbohydrate-protein interactions: basis of glycobiology. Acc. Chem. Res. 28: 321-327.
39. Lee, Y.C. et al. 1983. Binding of synthetic oligosaccharides to the hepatic gal galnac lectin-dependence on fine-structural features. J. Biol. Chem. 258: 199-202.
40. Khorev, O. et al. 2008. Trivalent, Gal/GalNAc-containing ligands designed for the asialoglycoprotein receptor. Bioorg. Med. Chem. 16: 5216-5231.
41. Westerlind, U. et al. 2004. Ligands of the asialoglycoprotein receptor for targeted gene delivery, part 1: synthesis of and binding studies with biotinylated cluster glycosides containing N-acetylgalactosamine. Glycoconj. J. 21: 227-241.
42. Rensen, P.C. et al. 2004. Design and synthesis of novel N-acetylgalactosamine-terminated glycolipids for targeting of lipoproteins to the hepatic asialoglycoprotein receptor. J. Med. Chem. 47: 5798-5808.
43. Pujol, A.M. et al. 2012. A sulfur tripod glycoconjugate releases a high affinity copper chelator in hepatocytes. Angew. Chem. Int. Ed. 51: 7445-7448.
44. Guo, Y. et al. 2005. NH2-terminal signals in ATP7B Cu-ATPase mediate its Cu-dependent anterograde traffic in polarized hepatic cells. Am. J. Physiol. Gastrointest. Liver Physiol. 289: G904-G916.
45. Zischka, H. et al. 2011. Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease. J. Clin. Invest. 121: 1508-1518.
46. Ralle, M. et al. 2010. Wilson disease at a single cell level: intracellular copper trafficking activates compartment-specific responses in hepatocytes. J. Biol. Chem. 285: 30875-30883.